This year’s SBAA annual alumni event featured a presentation by Ulthera, the Mesa, Arizona-based aesthetic therapeutic company, along with a dynamic panel consisting of Matt Likens (Ulthera CEO), Michael Peterson (Vice President, R&D), Justin Klein (NEA), and moderated by Alan Mendelson (Latham & Watkins). The jam packed event also consisted of a presentation by Jonathan Norris, Managing Director of Healthcare at Silicon Valley Bank, to provide a medtech investment update.
Ulthera’s signature technology is used in the Ultherapy procedure, which is FDA-cleared to lift skin above the eyebrow, on the neck and under the chin, as well as improve lines and wrinkles on the décolletage. The Ulthera System delivers micro-focused ultrasound energy at prescribed depths below the surface of the skin. It consists of a control unit & handpiece along with disposable transducers that provide recurring revenue.
The Innovations in Cardiovascular Interventions (ICI) Meeting, held in Israel every year, is an internationally renowned conference bringing together clinicians, researchers, and industry to provide a wide perspective on new technologies in the field of cardiology and cardiovascular surgery. Led by Prof. Chaim Lotan and Prof. Rafael Beyar, It is regularly attended by over 700 attendees from more than 40 countries. The next meeting will be held in Tel-Aviv at the David Intercontinental Hotel from Dec. 14-16.